Hepatitis C Information - Medivir: Candidate Drug Designated within the Tibotec ...

Medivir: Candidate Drug Designated within the Tibotec ...
Business Wire (press release), CA - Dec 29, 200529, 2005--The Hepatitis C Virus (HCV) collaboration with Tibotec Pharmaceuticals Ltd has recently designated a Candidate Drug (CD). ...

After many years, south county links appear headed for approval
Napa Valley Register, CA - Jan 5, 2006... On Wednesday, in less than an hour and with virtually all positive comments of support, HCV Napa Partners won approval for zoning and use permit modification ...

Know the ABCs of hepatitis
Packet Online, NJ - Dec 17, 2005... The most serious form of hepatitis hepatitis C (HCV) is considered an epidemic in this country. ... HCV is responsible for 8,000 to 10,000 deaths per year. ...

(Taiwan) Affymetrix and Vita Genomics collaborate to develop ...
Biotecheast.com, Taiwan - Dec 26, 2005... microarray technology to develop and market in-vitro diagnostic (IVD) tests for Alpha Interferon Treatment response in patients with HBV and HCV, as well as ...

Medivir Takes Its First Pharmaceutical Project Into Phase III and ...
Genetic Engineering News, NY - Dec 22, 2005... continue to make progress. -- The HCV protease project operated jointly with Tibotec continues to make progress. -- MIV-701, a potential ...